Fortis Healthcare Limited (NSE:FORTIS)
1,044.60
-10.85 (-1.03%)
Oct 30, 2025, 3:30 PM IST
Fortis Healthcare Revenue
Fortis Healthcare had revenue of 21.67B INR in the quarter ending June 30, 2025, with 16.56% growth. This brings the company's revenue in the last twelve months to 80.94B, up 14.09% year-over-year. In the fiscal year ending March 31, 2025, Fortis Healthcare had annual revenue of 77.86B with 12.88% growth.
Revenue (ttm)
80.94B
Revenue Growth
+14.09%
P/S Ratio
9.84
Revenue / Employee
6.61M
Employees
12,237
Market Cap
796.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 77.86B | 8.89B | 12.88% |
| Mar 31, 2024 | 68.97B | 6.00B | 9.52% |
| Mar 31, 2023 | 62.98B | 5.80B | 10.14% |
| Mar 31, 2022 | 57.18B | 16.87B | 41.87% |
| Mar 31, 2021 | 40.30B | -6.02B | -13.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Biocon | 157.71B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
Fortis Healthcare News
- 24 days ago - Fortis Healthcare shares jump over 3% today – Here’s why - Business Upturn
- 2 months ago - Fortis Healthcare signs O&M pact with Ekana Group for 550-bed super specialty hospital in Lucknow - Business Upturn
- 3 months ago - Fortis shares surge over 3% as Q1 revenue jumps 16.5% YoY to Rs 2,166 crore, net profit up 57% YoY - Business Upturn
- 3 months ago - Fortis Healthcare signs operation & maintenance deal with Gleneagles Healthcare India for 5 hospitals and 1 clinic - Business Upturn
- 7 months ago - Fortis Healthcare in focus: Subsidiary receives Rs 76.19 crore income tax demand for FY2019 - Business Upturn
- 7 months ago - Fortis Healthcare secures full ownership of ‘Fortis’ trademark for Rs 200 crore after Delhi High Court approval - Business Upturn
- 7 months ago - Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025] - Business Upturn
- 7 months ago - Fortis Healthcare receives injunction order related to Shrimann Hospital acquisition - Business Upturn